Skip navigation

 Login or Register | Member Centre

GlobeInvestorGOLD Canada's most comprehensive investment tool.

 
Change Symbol: Lookup Trade Now

AEterna Zentaris | Headlines

  • Vol:
  • Last Trade:
Search found 87 documents NextNext

1: AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology
CNW, November 11, 2009 08:35 AM

2: AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology
PR NEWSWIRE, November 11, 2009 08:35 AM

3: Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
PR NEWSWIRE, November 11, 2009 08:30 AM

4: AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results
CNW, November 11, 2009 07:00 AM

5: AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results
PR NEWSWIRE, November 11, 2009 07:00 AM

6: Ęterna Zentaris: Scientific Article Supports Perifosine's Development in Kidney Cancer
CNW, November 9, 2009 07:00 AM

7: AEterna Zentaris: Scientific Article Supports Perifosine's Development in Kidney Cancer
PR NEWSWIRE, November 9, 2009 07:00 AM

8: Ęterna Zentaris to Announce Third Quarter 2009 Financial and Operating Results on November 11, 2009
CNW, November 4, 2009 07:00 AM

9: AEterna Zentaris to Announce Third Quarter 2009 Financial and Operating Results on November 11, 2009
PR NEWSWIRE, November 4, 2009 07:00 AM

10: Ęterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer
CNW, November 2, 2009 07:00 AM

NextNext
 

Search using one or more of the following options:

Symbol Lookup
 
 
  Search Tips
 
  * Can only be used when searching The Globe and Mail and newswires.

Back to top